SHINEWAY PHARM_Providing professional financial news and data related to SHINEWAY PHARM, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Offshore Trust Insight | SHINEWAY PHARM (02877.HK): H1 Revenue of RMB 1.181 Billion as Controlling Shareholder's Family Trust Holds 66.12% Summary

Tags：

SHINEWAY PHARM 02877.HK Offshore Trust

2026-11-02

SHINEWAY PHARM (02877.HK): Appoints Kang Limin as Executive Director

Tags：

SHINEWAY PHARM 02877.HK Board Change

2026-10-30

Finance
EPIWORLD (02726.HK): Positive profit alert, revenue seen up 110%-130%
Research
Hong Kong AI Concept Stock Daily: XIAOMI-W Gains 6.12% as October Vehicle Deliveries Exceed 50,000 Units - 20261102
Finance
NewTimeSpace | Hong Kong Market Close: The Three Major Indices Continued to Strengthen, with the Hang Seng Index Closing Up 0.42%, While Themes Such as Electrical Equipment and Media Led the Gains
Research
Hong Kong Recently Listed Stocks Daily Report: Hydrogen Energy and Consumer Electronics Strengthen as the Pharmaceutical Sector Diverges Internally-20261102
Research
Monthly Hong Kong ETF Average Return Statistics (by Manager) (October 2026)
Research
HK shares ETFs Daily Report: E Fund (HK) CSI Liquor Index ETF Rises 3.68% to Lead as 10 ETFs Join the Stock Connect List — November 2, 2026
Research
Monthly Hong Kong ETF Return Statistics (October 2026)
Research
Offshore Trust Insight | SHINEWAY PHARM (02877.HK): H1 Revenue of RMB 1.181 Billion as Controlling Shareholder's Family Trust Holds 66.12% Summary
Research
HK Stock Connect Insight | TYK MEDICINES-B (02410.HK): Cut from the Stock Connect list on Sept 7, southbound stake falls from 36.50% to 28.39%
Research
HK Stock Connect Insight | DEEPZERO (02723.HK): H1 Revenue Up 43.6% YoY as H-Share Subdivision Takes Effect on October 16

Scan QR Code

Download App